Page last updated: 2024-11-05

tetraethylammonium and Hypoglycemia

tetraethylammonium has been researched along with Hypoglycemia in 2 studies

Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)

Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kherani, ZS1
Auer, RN1
Antoine, MH1
Berkenboom, G1
Fang, ZY1
Fontaine, J1
Herchuelz, A1
Lebrun, P1

Other Studies

2 other studies available for tetraethylammonium and Hypoglycemia

ArticleYear
Pharmacologic analysis of the mechanism of dark neuron production in cerebral cortex.
    Acta neuropathologica, 2008, Volume: 116, Issue:4

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Artifacts; Biopsy; Brain Ischemia; Cerebral Cortex; D

2008
Mechanical and ionic response of rat aorta to diazoxide.
    European journal of pharmacology, 1992, Jun-05, Volume: 216, Issue:2

    Topics: Animals; Aorta; Calcium; Calcium Radioisotopes; Diazoxide; Endothelium, Vascular; Hypoglycemia; Musc

1992